Product cited in:
Weisgraber, Mahley: "Apoprotein (E--A-II) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction." in: The Journal of biological chemistry, Vol. 253, Issue 17, pp. 6281-8, 1978 (PubMed).
Blanco-Vaca, Via, Yang et al.: "Characterization of disulfide-linked heterodimers containing apolipoprotein D in human plasma lipoproteins." in: Journal of lipid research, Vol. 33, Issue 12, pp. 1785-96, 1993 (PubMed).
Tsao, Wei, Robberson et al.: "Isolation and characterization of the human apolipoprotein A-II gene. Electron microscopic analysis of RNA:DNA hybrids, nucleotide sequence, identification of a polymorphic MspI site, and general structural organization of apolipoprotein genes." in: The Journal of biological chemistry, Vol. 260, Issue 28, pp. 15222-31, 1986 (PubMed).
Brewer, Lux, Ronan et al.: "Amino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complex." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 69, Issue 5, pp. 1304-8, 1972 (PubMed).
Gordon, Budelier, Sims et al.: "Biosynthesis of human preproapolipoprotein A-II." in: The Journal of biological chemistry, Vol. 258, Issue 22, pp. 14054-9, 1984 (PubMed).
Forte, Bielicki, Goth-Goldstein et al.: "Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT." in: Journal of lipid research, Vol. 36, Issue 1, pp. 148-57, 1995 (PubMed).
Warden, Hedrick, Qiao et al.: "Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II." in: Science (New York, N.Y.), Vol. 261, Issue 5120, pp. 469-72, 1993 (PubMed).
Schultz, Verstuyft, Gong et al.: "Protein composition determines the anti-atherogenic properties of HDL in transgenic mice." in: Nature, Vol. 365, Issue 6448, pp. 762-4, 1993 (PubMed).
Weng, Breslow: "Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 93, Issue 25, pp. 14788-94, 1997 (PubMed).
Fidge: "High density lipoprotein receptors, binding proteins, and ligands." in: Journal of lipid research, Vol. 40, Issue 2, pp. 187-201, 2001 (PubMed).
Durbin, Jonas: "Lipid-free apolipoproteins A-I and A-II promote remodeling of reconstituted high density lipoproteins and alter their reactivity with lecithin:cholesterol acyltransferase." in: Journal of lipid research, Vol. 40, Issue 12, pp. 2293-302, 2000 (PubMed).
Gillard, Chen, Gaubatz et al.: "Plasma factors required for human apolipoprotein A-II dimerization." in: Biochemistry, Vol. 44, Issue 2, pp. 471-9, 2005 (PubMed).
Malik, Ward, Gupta et al.: "Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 11, Issue 3, pp. 1073-85, 2005 (PubMed).
Birjmohun, Dallinga-Thie, Kuivenhoven et al.: "Apolipoprotein A-II is inversely associated with risk of future coronary artery disease." in: Circulation, Vol. 116, Issue 18, pp. 2029-35, 2007 (PubMed).